Breaking News Instant updates and real-time market news.

WBA

Walgreens Boots Alliance

$63.73

0.42 (0.66%)

06:20
07/10/18
07/10
06:20
07/10/18
06:20

Walgreens Boots Alliance downgraded to In Line from Outperform at Evercore ISI

WBA Walgreens Boots Alliance
$63.73

0.42 (0.66%)

07/02/18
MZHO
07/02/18
DOWNGRADE
Target $64
MZHO
Neutral
Walgreens Boots Alliance downgraded to Neutral from Buy at Mizuho
Mizuho analyst Ann Hynes downgraded Walgreens Boots Alliance (WBA) to Neutral with a reduced price target of $64. Shares of Walgreens are unlikely to outperform given the new competitive threat of Amazon (AMZN), a lack of revenue diversification and lack of a clear strategy on how the company will compete in a consolidating industry, Hynes tells investors in a research note. She believes the stock's valuation no longer justifies a Buy rating.
07/02/18
LEHM
07/02/18
NO CHANGE
LEHM
Equal Weight
Express Scripts most exposed to mail order market disruption, says Barclays
Barclays analyst Steve Valiquette believes Express Scripts (ESRX) is most exposed to Amazon's (AMZN) acquisition of PillPack. The analyst estimates Express Scripts has 35%-40% share of the U.S. prescription mail order market. The mail order prescription market is the most immediate area for possible disruption from Amazon/PillPack given the nature of PillPack's business and Amazon's existing mail-order logistical infrastructure, Valiquette tells investors in a research note. The analyst assumes PillPack captures 1% share of the U.S. mail-order Rx market in 2019, and improves its market share further by 1% each year afterwards. Valiquette calculates a "hypothetical" 13c negative earnings per share impact for Express Scripts in 2019. He believes the negative earnings impact could reach 45c by 2021, but thinks Express Scripts could undertake expense cuts to offset some of this. For Walgreens Boots Alliance (WBA), the analyst calculates a negative earnings per share impact of 15c in 2020, or 2% of his current estimate assuming no additional cost-cutting. Valiquette has Equal Weight ratings on both Express Scripts and Walgreens.
07/09/18
SBSH
07/09/18
DOWNGRADE
Target $69
SBSH
Neutral
Walgreens Boots Alliance downgraded to Neutral from Buy at Citi
Citi analyst Ralph Giacobbe downgraded Walgreens Boots Alliance (WBA) to Neutral after assuming coverage of the name. The analyst lowered his price target for the shares to $69 from $76. The analyst finds it difficult to argue for "meaningful multiple expansion" given headwinds from industry pressures and a dynamic and changing backdrop. Further, Amazon's (AMZN) recent acquisition of PillPack reignites "further competitive fears," Giacobbe tells investors in a research note.
07/09/18
07/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Jefferies with analyst Kevin Grundy saying slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower. 2. SeaWorld (SEAS) and Six Flags (SIX) were downgraded to Market Perform from Outperform at Wells Fargo. 3. Walgreens Boots Alliance (WBA) downgraded to Neutral from Buy at Citi with analyst Ralph Giacobbe saying he finds it difficult to argue for "meaningful multiple expansion" given headwinds from industry pressures and a dynamic and changing backdrop. 4. Flowers Foods (FLO) downgraded to Hold from Buy at Vertical Group. 5. Wayfair (W) downgraded to Market Perform from Outperform with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

RRC

Range Resources

$16.52

-0.18 (-1.08%)

15:04
10/23/18
10/23
15:04
10/23/18
15:04
Options
Range Resources options imply 8.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

15:01
10/23/18
10/23
15:01
10/23/18
15:01
Hot Stocks
NY DFS authorizes Coinbase Global to form Coinbase Custody Trust Company »

New York Financial…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$51.59

-0.05 (-0.10%)

15:01
10/23/18
10/23
15:01
10/23/18
15:01
Hot Stocks
Wells Fargo raises share repurchase authority by 350M shares »

The Wells Fargo board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

HLT

Hilton

$69.20

-0.97 (-1.38%)

15:00
10/23/18
10/23
15:00
10/23/18
15:00
Options
Hilton options see continued interest ahead of earnings »

Hilton options see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

15:00
10/23/18
10/23
15:00
10/23/18
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TSLA

Tesla

$292.51

31.48 (12.06%)

14:55
10/23/18
10/23
14:55
10/23/18
14:55
Hot Stocks
Citron's Left says would be 'wrong' to be short Tesla ahead of Q3 report »

Citron Research's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IBTX

Independent Bank

$57.55

1.08 (1.91%)

14:54
10/23/18
10/23
14:54
10/23/18
14:54
Recommendations
Independent Bank analyst commentary  »

Independent Bank price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 09

    Nov

HXL

Hexcel

14:52
10/23/18
10/23
14:52
10/23/18
14:52
Upgrade
Hexcel rating change  »

Hexcel upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CVE

Cenovus Energy

$8.53

-0.085 (-0.99%)

14:50
10/23/18
10/23
14:50
10/23/18
14:50
Options
Afternoon call buyer in Cenovus Energy »

Afternoon call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:50
10/23/18
10/23
14:50
10/23/18
14:50
General news
Fed's Kaplan reiterated the FOMC should gradual reduce accommodation »

Fed's Kaplan…

TXN

Texas Instruments

$99.84

0.1 (0.10%)

14:49
10/23/18
10/23
14:49
10/23/18
14:49
Options
Texas Instruments options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BIIB

Biogen

$319.27

3.6 (1.14%)

14:47
10/23/18
10/23
14:47
10/23/18
14:47
Recommendations
Biogen analyst commentary  »

Piper a buyer of Biogen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

TSLA

Tesla

$292.44

31.41 (12.03%)

14:44
10/23/18
10/23
14:44
10/23/18
14:44
Hot Stocks
Musk says Tesla will cut some interior configuration options for Model S, X »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

VNQ

Vanguard REIT Index Fund

$77.68

0.64 (0.83%)

14:40
10/23/18
10/23
14:40
10/23/18
14:40
Options
66K Vanguard Real Estate Fund Dec 76 - Jan 72 put spreads trade 71c »

66K Vanguard Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEEV

Veeva

$88.99

-2.77 (-3.02%)

14:35
10/23/18
10/23
14:35
10/23/18
14:35
Options
Veeva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
10/23/18
10/23
14:35
10/23/18
14:35
General news
Fed Board minutes showed showed most Banks supported the September 26 rate hike »

Fed Board minutes showed…

TSLA

Tesla

$292.00

30.97 (11.86%)

14:32
10/23/18
10/23
14:32
10/23/18
14:32
Recommendations
Tesla analyst commentary  »

Tesla's moved up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

TTWO

Take-Two

$118.82

-1.69 (-1.40%)

14:30
10/23/18
10/23
14:30
10/23/18
14:30
Periodicals
'Red Dead Redemption 2' development a difficult experience, Kotaku says »

Take-Two's Rockstar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

, HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

14:29
10/23/18
10/23
14:29
10/23/18
14:29
Recommendations
Selecta Biosciences, Horizon Pharma analyst commentary  »

Selecta SEL-212 data…

SELB

Selecta Biosciences

$9.25

-4.12 (-30.82%)

HZNP

Horizon Pharma

$18.49

-0.76 (-3.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

BCS

Barclays

$8.60

0.11 (1.30%)

14:20
10/23/18
10/23
14:20
10/23/18
14:20
Options
8-strike put buyers in Barclays Bank ahead of earnings »

8-strike put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SELB

Selecta Biosciences

$8.93

-4.44 (-33.21%)

14:19
10/23/18
10/23
14:19
10/23/18
14:19
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLG

SL Green Realty

$92.15

0.36 (0.39%)

14:18
10/23/18
10/23
14:18
10/23/18
14:18
Downgrade
SL Green Realty rating change  »

SL Green Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/23/18
10/23
14:17
10/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$133.39

-7.945 (-5.62%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Recommendations
Centene analyst commentary  »

Centene should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 14

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/23/18
10/23
14:16
10/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.